Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex and postoperative pulmonary complications in older adults after major non-cardiac surgery
ChiCTR2500096287Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jan 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Sugammadex in postoperative respiratory complications (PRC) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Incidence of postoperative pulmonary complications during hospitalization. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
Sugammadex
03
Conditions
postoperative respiratory complications (PRC)
Beyond the preview
Go deeper on ChiCTR2500096287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096287.